OBJECTIVE: The objective was to examine the association between serious mental illness and quality of care for myocardial infarction among disabled Maryland Medicaid beneficiaries. METHODS: We conducted a retrospective cohort study of disabled Maryland Medicaid beneficiaries with myocardial infarction from 1994 to 2004. Cardiac procedures and guideline-based medication use were compared for persons with and without serious mental illness. RESULTS: Of the 633 cohort members with myocardial infarction, 137 had serious mental illness. Serious mental illness was not associated with differences in receipt of cardiac procedures or guideline-based medications. Overall use of guideline-based medications was low; 30 days after the index hospitalization for myocardial infarction, 19%, 35% and 11% of cohort members with serious mental illness and 22%, 37% and 13% of cohort members without serious mental illness had any use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers and statins, respectively. Study participants with and without serious mental illness had similar rates of mortality. Overall, use of beta-blockers [hazard ratio 0.93, 95% confidence interval (CI) 0.90-0.97] and statins (hazard ratio 0.93, 95% CI 0.89-0.98) was associated with reduced risk of mortality. CONCLUSIONS: Quality improvement programs should consider how to increase adherence to medications of known benefit among disabled Medicaid beneficiaries with and without serious mental illness.
OBJECTIVE: The objective was to examine the association between serious mental illness and quality of care for myocardial infarction among disabled Maryland Medicaid beneficiaries. METHODS: We conducted a retrospective cohort study of disabled Maryland Medicaid beneficiaries with myocardial infarction from 1994 to 2004. Cardiac procedures and guideline-based medication use were compared for persons with and without serious mental illness. RESULTS: Of the 633 cohort members with myocardial infarction, 137 had serious mental illness. Serious mental illness was not associated with differences in receipt of cardiac procedures or guideline-based medications. Overall use of guideline-based medications was low; 30 days after the index hospitalization for myocardial infarction, 19%, 35% and 11% of cohort members with serious mental illness and 22%, 37% and 13% of cohort members without serious mental illness had any use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers and statins, respectively. Study participants with and without serious mental illness had similar rates of mortality. Overall, use of beta-blockers [hazard ratio 0.93, 95% confidence interval (CI) 0.90-0.97] and statins (hazard ratio 0.93, 95% CI 0.89-0.98) was associated with reduced risk of mortality. CONCLUSIONS: Quality improvement programs should consider how to increase adherence to medications of known benefit among disabled Medicaid beneficiaries with and without serious mental illness.
Authors: Gail L Daumit; Richard W Goldberg; Christopher Anthony; Faith Dickerson; Clayton H Brown; Julie Kreyenbuhl; Karen Wohlheiter; Lisa B Dixon Journal: J Nerv Ment Dis Date: 2005-10 Impact factor: 2.254
Authors: Joseph P McEvoy; Jonathan M Meyer; Donald C Goff; Henry A Nasrallah; Sonia M Davis; Lisa Sullivan; Herbert Y Meltzer; John Hsiao; T Scott Stroup; Jeffrey A Lieberman Journal: Schizophr Res Date: 2005-08-30 Impact factor: 4.939
Authors: Susan L McElroy; Mark A Frye; Trisha Suppes; Dawn Dhavale; Paul E Keck; Gabriele S Leverich; Lori Altshuler; Kirk D Denicoff; Willem A Nolen; Ralph Kupka; Heinz Grunze; Jorg Walden; Robert M Post Journal: J Clin Psychiatry Date: 2002-03 Impact factor: 4.384
Authors: Gail L Daumit; Jeanne M Clark; Donald M Steinwachs; Camelia M Graham; Anthony Lehman; Daniel E Ford Journal: J Nerv Ment Dis Date: 2003-12 Impact factor: 2.254
Authors: Julie Kreyenbuhl; Lisa B Dixon; John F McCarthy; Soheil Soliman; Rosalinda V Ignacio; Marcia Valenstein Journal: Schizophr Bull Date: 2008-08-20 Impact factor: 9.306
Authors: Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes Journal: PLoS One Date: 2022-08-18 Impact factor: 3.752
Authors: Karly A Murphy; Arlene Dalcin; Emma E McGinty; Stacy Goldsholl; Ann Heller; Gail L Daumit Journal: Front Psychiatry Date: 2021-12-22 Impact factor: 4.157